These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33209882)

  • 1. Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Li L; Liu G; Jin K; Lu H; Zhai X; Zhou M; Yue K; Duan Y; Wu Y; Wang X
    Ann Transl Med; 2020 Oct; 8(20):1302. PubMed ID: 33209882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy.
    Zhang HQ; Wang RB; Yan HJ; Zhao W; Zhu KL; Jiang SM; Hu XG; Yu JM
    Asian Pac J Cancer Prev; 2012; 13(1):199-203. PubMed ID: 22502668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma.
    Yuan C; Yang K; Tang H; Chen D
    Onco Targets Ther; 2016; 9():3381-6. PubMed ID: 27350753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
    Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
    Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment circulating neutrophil count is an independent prognostic factor in oropharyngeal cancer.
    Li L; Liu G; Lu H; Jin K; Zhai X; Zhou M; Duan Y; Yue K; Wu Y; Wang X
    Ann Transl Med; 2020 Sep; 8(18):1135. PubMed ID: 33240984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Burningham K; Moore W; Moon D; Avkshtol V; Day AT; Sumer B; Vo D; Bishop JA; Hughes R; Sher DJ
    Oral Oncol; 2021 Dec; 123():105623. PubMed ID: 34801975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum cytokeratin 19 fragment in the prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer].
    Xu C; Liu J; Xing L; Liu S
    Zhongguo Fei Ai Za Zhi; 2010 Oct; 13(10):954-61. PubMed ID: 20959068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
    Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
    Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 16. A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy.
    Liu C; Han J; Han D; Huang W; Li B
    J Thorac Dis; 2023 Apr; 15(4):2116-2128. PubMed ID: 37197526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Guo TW; Saiyed F; Yao CMKL; Kiong KL; Martinez J; Sacks R; Lee JJ; Moreno AC; Frank SJ; Rosenthal DI; Glisson BS; Ferrarotto R; Mott FE; Johnson FM; Myers JN
    Cancer; 2021 Aug; 127(16):2916-2925. PubMed ID: 33873251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.